Amer Sami

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

John R. Mackey, Miguel Martín, Tadeusz Pieńkowski et al. · The Lancet Oncology · 2012 · 223 citations

Medicine, Oncology, Pharmacology +15

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

Xavier Pivot, Joseph Gligorov, Volkmar Müller et al. · Annals of Oncology · 2014 · 176 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Extrapulmonary small cell cancer

Kamal Haider, Rabia Shahid, Daygen L. Finch et al. · Cancer · 2006 · 123 citations · Full text

Medicine, Oncology, Gynecologic Oncology +12

Early Discontinuation but Not the Timing of Adjuvant Therapy Affects Survival of Patients With High-Risk Colorectal Cancer: A Population-Based Study

Shahid Ahmed, Imran Ahmad, Tong Zhu et al. · Diseases of the Colon & Rectum · 2010 · 53 citations

Medicine, Oncology, Surgery +17